EpiCare@Home Validation Study for Focal Onset Seizures

Last updated: February 10, 2023
Sponsor: Byteflies
Overall Status: Active - Recruiting

Phase

N/A

Condition

Epilepsy

Treatment

N/A

Clinical Study ID

NCT05738226
BF0002
  • Ages > 12
  • All Genders

Study Summary

The goal of this clinical trial is to validate a wearable seizure monitoring device, EpiCare@Home, as an objective seizure monitoring tool for people with focal onset epileptic seizures. The device continuously records brain, cardiorespiratory, and physical activity data.

The study aims to 1) collect benchmark data for seizure detection algorithm development and validation, and 2) evaluate the performance of the device in clinical and at home workflows.

Participants will wear the device during a routine Epilepsy Monitoring Unit (EMU) admission. Additionally, they can continue wearing the device at home after the EMU admission.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult (age ≥ 18) and adolescent (12 ≤ age < 18) patients with a known history orsuspicion of focal onset epilepsy, including focal-to-bilateral tonic-clonic seizures
  • A clinical indication for ≥ 1 h EMU observation.
  • Participants should be able to maintain a seizure diary in the provided EpiCare@HomePatient App (themselves or via a caregiver). Alternatively, the use of a paper seizurediary is allowed.

Exclusion

Exclusion Criteria:

  • Inability to provide written informed consent, either direct or via a proxy.
  • Known allergy or skin-sensitivity to the materials used in the Byteflies Adhesives orany 3rd party biopotential electrode.
  • Having an implanted device may be grounds for exclusion, depending on the type andlocation of the implant. Implanted devices, such as (but not limited to) pacemakers,cardioverter defibrillators (ICD), and/or neural stimulation devices may containmagnetic switches. Byteflies Sensor Dots contain magnets that may interfere with theoperation of these devices. The chance of this happening based on the strength of themagnets is exceedingly low (for comparison, the magnet strength is 10x lower than whatis found in Apple Magsafe cases) but it has not been excluded by formal testingeither. The risk will be evaluated on a case-by-case basis.
  • Any other condition or finding that would compromise the safety of the participant orthe quality of the study data, or otherwise interfere with achieving the studyobjectives, as determined by the investigator or research coordinator.

Study Design

Total Participants: 80
Study Start date:
January 23, 2023
Estimated Completion Date:
December 31, 2023

Study Description

Epilepsy, a neurological disorder characterized by recurrent epileptic seizures of often complex etiology, affects 65 million people globally. The current reference for home use is self-reported outcomes (typically via a seizure diary) which leads to significant under and inaccurate reporting of seizures. As seizure counting is the basis for many medical decisions, the ability to accurately and unobtrusively log seizures during activities of daily living would: 1) improve clinical practice by reducing the need for patients to spend time in an Epilepsy Monitoring Unit (EMU) and more quickly identify an appropriate treatment plan; and 2) provide a means to collect real-world data (RWD) for research and clinical purposes.

EpiCare@Home is a multimodal device that can continuously record EEG with unobtrusive behind-the-ear electrodes, in addition to cardiorespiratory and physical motion data. The device is intended to be used by a trained healthcare professional (HCP) as a clinical decision support tool during the management of people with epilepsy.

The clinical trial aims to analytically validate the performance of the seizure detection component of the device, specifically for focal onset seizures. In addition, it intends to clinically validate the ability of the device to support clinical workflows, from the perspective of healthcare professional and patient users alike.

Connect with a study center

  • Thomas Jefferson University

    Philadelphia, Pennsylvania 19107
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.